Brooklyn Investment Group’s Verve Therapeutics VERV Stock Holding History

Brooklyn Investment Group’s Portfolio VERV Stock Details VERV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-17,417	Closed	-$197K	–	1561
2025 Q3	$197K	Hold	17,417	–	–	0.03%	595
2025 Q2	$196K	Buy	+17,417	New	+$99.3K	0.03%	623
2025 Q1	–	Sell	-1,810	Closed	-$10.2K	–	2889
2024 Q4	$10.2K	Buy	+1,810	New	+$10.2K	﹤0.01%	966

Other funds holding VERV

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Brooklyn Investment Group's VERV Position: Q4 2025 in Review

Brooklyn Investment Group sold out of Verve Therapeutics (VERV) in Q4 2025, closing a stake of 17,417 shares — an estimated $197K sold.

Brooklyn Investment Group first reported a position in VERV in Q4 2024 and held it in 3 quarters. The position peaked at $197K in Q3 2025. 1 fund tracked by Wall St. Rank holds VERV as of Q4 2025.

Brooklyn Investment Group reported no remaining Verve Therapeutics position as of Q4 2025 after selling out during the quarter.
Brooklyn Investment Group sold 17,417 Verve Therapeutics shares in Q4 2025, an estimated $197K.
Brooklyn Investment Group first reported a position in Verve Therapeutics in Q4 2024 and held it in 3 quarters.
Brooklyn Investment Group's Verve Therapeutics position peaked at $197K in Q3 2025.
1 fund tracked by Wall St. Rank held Verve Therapeutics as of Q4 2025.

Based on Brooklyn Investment Group's 13F filing for Q4 2025, filed 12 Feb 2026.